PROS1 and COVID-19: In support of this, apart from a higher prevalence of aPLA, a recent study has confirmed prothrombotic potential of peripheral blood in patients hospitalized with COVID-19, showing decreased levels of natural plasma anticoagulants (protein C 17% lower, free protein S 22% lower) and unchanged thrombin generation capacity when compared to controls.